Parata provides BD access to a new $600 million pharmacy automation market segment that is expected to grow approximately 10% annually to $1.5 billion in the United States alone over 10 years, according to the company.
This webinar will discuss how healthcare communication operations can better use carrier technologies and customer contact intelligence to increase patient engagement.
The medication is indicated for the treatment of active duodenal ulcer, active gastric ulcer and symptomatic nonerosive gastroesophageal reflux disease.
